Javaria Mona Khalid

755 total citations
31 papers, 517 citations indexed

About

Javaria Mona Khalid is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Javaria Mona Khalid has authored 31 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 18 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Javaria Mona Khalid's work include Inflammatory Bowel Disease (24 papers), Microscopic Colitis (18 papers) and Eosinophilic Esophagitis (6 papers). Javaria Mona Khalid is often cited by papers focused on Inflammatory Bowel Disease (24 papers), Microscopic Colitis (18 papers) and Eosinophilic Esophagitis (6 papers). Javaria Mona Khalid collaborates with scholars based in United Kingdom, United States and Canada. Javaria Mona Khalid's co-authors include Brian G. Feagan, Jean‐Frédéric Colombel, Edward V. Loftus, Stefan Schreiber, Dirk Demuth, Greg Hather, Axel Dignaß, Laurent Peyrin‐Biroulet, Mahmoud Mosli and Charlie Cao and has published in prestigious journals such as Gastroenterology, Journal of Clinical Epidemiology and The American Journal of Gastroenterology.

In The Last Decade

Javaria Mona Khalid

29 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javaria Mona Khalid United Kingdom 10 349 256 164 94 53 31 517
Jingan Lou China 11 115 0.3× 89 0.3× 102 0.6× 68 0.7× 23 0.4× 49 483
María Dolores Martin‐Arranz Spain 13 384 1.1× 248 1.0× 254 1.5× 162 1.7× 51 1.0× 88 638
Pantelis Karatzas Greece 9 327 0.9× 246 1.0× 152 0.9× 130 1.4× 37 0.7× 22 510
Jennifer Coukos United States 9 219 0.6× 209 0.8× 158 1.0× 72 0.8× 8 0.2× 18 666
Maël Pagenault France 15 79 0.2× 114 0.4× 321 2.0× 14 0.1× 46 0.9× 39 522
Alexandra James United States 10 456 1.3× 409 1.6× 171 1.0× 130 1.4× 35 0.7× 20 634
Emily C L Wong Canada 15 439 1.3× 310 1.2× 213 1.3× 46 0.5× 23 0.4× 73 595
Ignace Dalle Belgium 7 178 0.5× 193 0.8× 132 0.8× 60 0.6× 23 0.4× 14 410
Luis Uscanga Mexico 17 127 0.4× 215 0.8× 509 3.1× 47 0.5× 20 0.4× 45 744
Ana Rita Gonçalves Portugal 9 283 0.8× 227 0.9× 124 0.8× 78 0.8× 24 0.5× 28 374

Countries citing papers authored by Javaria Mona Khalid

Since Specialization
Citations

This map shows the geographic impact of Javaria Mona Khalid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javaria Mona Khalid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javaria Mona Khalid more than expected).

Fields of papers citing papers by Javaria Mona Khalid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javaria Mona Khalid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javaria Mona Khalid. The network helps show where Javaria Mona Khalid may publish in the future.

Co-authorship network of co-authors of Javaria Mona Khalid

This figure shows the co-authorship network connecting the top 25 collaborators of Javaria Mona Khalid. A scholar is included among the top collaborators of Javaria Mona Khalid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javaria Mona Khalid. Javaria Mona Khalid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bingham, Clifton O., David Walker, Peter Nash, et al.. (2022). The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies. Arthritis Research & Therapy. 24(1). 11–11. 6 indexed citations
2.
3.
Feagan, Brian G., William J. Sandborn, Jean‐Frédéric Colombel, et al.. (2018). Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials. Journal of Crohn s and Colitis. 13(1). 50–57. 53 indexed citations
4.
Feagan, Brian G., Karen Lasch, Trevor Lissoos, et al.. (2018). Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology. 17(1). 130–138.e7. 73 indexed citations
5.
Jansen, Jeroen P., Javaria Mona Khalid, Michael Smyth, & Haridarshan Patel. (2018). The number needed to treat and relevant between-trial comparisons of competing interventions. ClinicoEconomics and Outcomes Research. Volume 10. 865–871. 4 indexed citations
6.
Schreiber, Stefan, Axel Dignaß, Laurent Peyrin‐Biroulet, et al.. (2018). Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease. Journal of Gastroenterology. 53(9). 1048–1064. 115 indexed citations
7.
Panés, Julián, Walter Reinisch, Shahnaz Khan, et al.. (2018). Burden and outcomes for complex perianal fistulas in Crohn’s disease: Systematic review. World Journal of Gastroenterology. 24(42). 4821–4834. 62 indexed citations
8.
Feagan, Brian G., Stefan Schreiber, Douglas C. Wolf, et al.. (2018). Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis. Inflammatory Bowel Diseases. 25(6). 1028–1035. 21 indexed citations
9.
Vermeire, Séverine, Edward V. Loftus, Jean‐Frédéric Colombel, et al.. (2017). Long-Term Effectiveness and Safety of Vedolizumab in Patients with Crohn’s Disease: 5-Year Cumulative Exposure of Gemini 2 Completers Rolling Into the Gemini Open-Label Extension Study. Gastroenterology. 152(5). S601–S601. 9 indexed citations
10.
Feagan, Brian G., Fatima Bhayat, Javaria Mona Khalid, et al.. (2017). Incidence of Pneumonia and Other Respiratory Tract Infections with Vedolizumab Treatment for Inflammatory Bowel Disease: Clinical Trial Experience. Gastroenterology. 152(5). S580–S581. 1 indexed citations
11.
Stallmach, Andreas, Bernd Bokemeyer, Jeffrey Axler, et al.. (2017). DOP026 Sustained remission with vedolizumab in patients with moderately to severely active ulcerative colitis: a GEMINI 1 post hoc analysis of week 14 remitters. Journal of Crohn s and Colitis. 11(suppl_1). S42–S43. 1 indexed citations
12.
Hather, Greg, et al.. (2017). P305 Indirect comparison of two novel biologics for the treatment of Crohn's disease : network-meta analysis of ustekinumab vs vedolizumab. Journal of Crohn s and Colitis. 11(suppl_1). S232–S233. 4 indexed citations
13.
Feagan, Brian G., Karen Lasch, Javaria Mona Khalid, et al.. (2017). Vedolizumab Demonstrates Early Symptomatic Improvement in Ulcerative Colitis: A GEMINI 1 Post hoc Analysis. The American Journal of Gastroenterology. 112. S371–S373. 3 indexed citations
14.
15.
Khalid, Javaria Mona, Laurent Peyrin‐Biroulet, Alessandro Armuzzi, et al.. (2016). Predictors of Non-response or Loss of Response to Tumour Necrosis Factor Antagonist Therapies in Inflammatory Bowel Disease. The American Journal of Gastroenterology. 111. S316–S316. 1 indexed citations
16.
Khalid, Javaria Mona, et al.. (2016). Patterns of Dose Escalation Amongst Patients with Ulcerative Colitis and Crohnʼs Disease Treated with Vedolizumab vs. Infliximab in the United States. The American Journal of Gastroenterology. 111. S316–S317. 1 indexed citations
17.
Leal, José, et al.. (2014). Synthesis framework estimating prevalence of MCADD and sensitivity of newborn screening programme in the absence of direct evidence. Journal of Clinical Epidemiology. 67(10). 1131–1138. 2 indexed citations
18.
Knowles, Rachel L, et al.. (2013). Late clinical presentation of congenital adrenal hyperplasia in older children: findings from national paediatric surveillance. Archives of Disease in Childhood. 99(1). 30–34. 21 indexed citations
19.
Khalid, Javaria Mona, et al.. (2013). Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study. BMC Dermatology. 13(1). 9–9. 24 indexed citations
20.
Khalid, Javaria Mona, G. T. N. Besley, R. Neil Dalton, et al.. (2011). Newborn screening for medium chain acyl-CoA dehydrogenase deficiency in England: Prevalence, predictive value and test validity based on 1.5 million screened babies. Journal of Medical Screening. 18(4). 173–181. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingan Lou Breakdown of academic impact, for papers by María Dolores Martin‐Arranz Breakdown of academic impact, for papers by Pantelis Karatzas Breakdown of academic impact, for papers by Jennifer Coukos Breakdown of academic impact, for papers by Maël Pagenault Breakdown of academic impact, for papers by Alexandra James Breakdown of academic impact, for papers by Emily C L Wong Breakdown of academic impact, for papers by Ignace Dalle Breakdown of academic impact, for papers by Luis Uscanga Breakdown of academic impact, for papers by Ana Rita Gonçalves
Rankless by CCL
2026